title: Sciatic nerve resection in the thigh: a functional evaluation.
abstract: Patients with a soft tissue malignancy involving the sciatic nerve who present with neurologic loss generally are advised to have an amputation. Twenty patients who underwent limb-sparing procedures with complete resection of the sciatic nerve as treatment for neurofibrosarcomas (12 patients), liposarcomas (four patients), malignant fibrous histiocytomas (two patients), recurrent desmoid tumor (one patient), and epithelioid hemangioendothelioma (one patient) were reviewed retrospectively. The mean age of these nine women and 11 men at the time of surgery was 51 years (range, 28-84 years). The right sciatic nerve was affected in 12 patients. These tumors were large and high grade. A mean of 22 cm of the nerve had to be resected (range, 8-42 cm). Ten patients received preoperative radiotherapy and 16 patients had intraoperative or postoperative radiotherapy. At a mean followup of 35 months (range, 7-97 months), 14 of the 20 patients were alive. Two patients had local recurrences develop (10%), whereas 12 patients had distant metastases. The function of the 10 patients as assessed by the Toronto Extremity Salvage Score averaged 74%. Most patients indicated that walking in the house is not difficult, but walking is compromised as soon as an effort is needed. Four patients walk without a cane, four needed one cane, and two needed two canes. The patients experienced stiffness, a sense of numbness, and premature fatigue. The use of analgesics was infrequent. Generally, patients rated themselves to be mildly to moderately disabled. From this small number of patients, it is shown that a tumor involving the sciatic nerve can be treated by limb-sparing surgery, including complete nerve resection, as an alternative to hip disarticulation or hindquarter amputation because the limb salvage option provides an acceptable functional outcome.
authors.affiliation: Mayo Clinic, Department of Orthopedics, Rochester, MN 55905, USA.
authors.forename: B
authors.initials: B
authors.lastname: Fuchs
authors.forename: A M
authors.initials: AM
authors.lastname: Davis
authors.forename: J S
authors.initials: JS
authors.lastname: Wunder
authors.forename: R S
authors.initials: RS
authors.lastname: Bell
authors.forename: B A
authors.initials: BA
authors.lastname: Masri
authors.forename: M
authors.initials: M
authors.lastname: Isler
authors.forename: R
authors.initials: R
authors.lastname: Turcotte
authors.forename: M G
authors.initials: MG
authors.lastname: Rock
mesh_terms: D000203:Activities of Daily Living; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000700:Analgesics / Q000627:therapeutic use; D002183:Canes; D003884:Dermoid Cyst / Q000601:surgery; D006233:Persons with Disabilities; D005221:Fatigue / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D018323:Hemangioendothelioma, Epithelioid / Q000601:surgery; D018219:Histiocytoma, Benign Fibrous / Q000601:surgery; D006801:Humans; D006987:Hypesthesia / Q000209:etiology; D008080:Liposarcoma / Q000601:surgery; D008297:Male; D008875:Middle Aged; D018319:Neurofibrosarcoma / Q000601:surgery; D010524:Peripheral Nervous System Neoplasms / Q000601:surgery*; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D012584:Sciatic Nerve / Q000601:surgery*; D020426:Sciatic Neuropathy / Q000601:surgery*; D015996:Survival Rate; D016896:Treatment Outcome; D016138:Walking / Q000502:physiology
chemical_list: D000700:Analgesics